New Product Development
new product development
R2’s Product development is focused on the process of designing, creating and marketing new medically advanced, cannabinoid derivative products and services to benefit physicians and their patients. R2’s discipline is motivated on developing and delivering systematic methods for guiding all the processes involved in bringing new products to market, quickly and effectively supported by clinical research, trials and a successful patient result and experience.
Upon completion of our adult respiratory, asthma products, R2’s direction will be to continue clinical trials to parallel development of similar products for pediatric asthma, COPD and Emphysema.
R2’s Product development involves improving on existing technologies and, or products that we see as deficient within a market segment and targeting a particular market segment such as the $10 Billion annual Asthma and Respiratory market.
Consistent product development and constant improvement is a necessity for R2, as we strive to lead and stay ahead of changes and trends in the marketplace to ensure our future profitability and success. A core competitive product development strategy is our company-wide commitment to creating items that fulfill particular physicians and consumer needs or characteristics. These characteristics include medical practitioners and consumers' desire for products that are high-quality or lower-cost; products that provide the end-user with alternatives to previously prescribed remedies that exhibit potentially harmful side-effects and, or adverse reactions to prescribed medications.
